SIX2, like SIX1, overexpression was detected in breast cancer (Wang et al., 2014; Oliphant et al., 2019) and appeared to promote increased survival, self-renewal, and metastasis of tumor cells (Table 2). Here, SIX1 is linked to neoplasm.